Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of May 2025. The report specifically details a transaction in the company's own shares executed under its share buyback programme announced on March 28, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity figures. It focuses exclusively on share repurchase activity.
- Shares Purchased: 810,332 ordinary shares
- Purchase Date: May 21, 2025
- Highest Price Paid: 413.60 pence per share
- Lowest Price Paid: 407.40 pence per share
- Volume Weighted Average Price: 410.94 pence per share
- Post-Transaction Share Capital: 9,010,139,389 ordinary shares
- Treasury Shares Held: 4,080,205
- Voting Shares Outstanding: 9,006,059,184
Material Changes
Following the settlement of the buyback transaction, the number of ordinary shares with voting rights decreased to 9,006,059,184. This figure is relevant for shareholders determining notification requirements under the FCA's Disclosure Guidance and Transparency Rules.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. It serves strictly as a regulatory disclosure of a specific share transaction.
Investor Verification Checklist
- Verify the total number of shares purchased (810,332) and the average price paid (410.94 pence) against the company's broader buyback programme limits.
- Confirm the updated count of voting shares (9,006,059,184) for regulatory threshold calculations.
- Review the full trade breakdown available via the provided London Stock Exchange link for granular transaction details.